A DESIGNED HIGH THROUGHPUT DRUG SCREENING STRATEGY IDENTIFIES AURORA KINASE A INHIBITORS AS PROMISING PRECLINICAL CANDIDATES FOR THE TREATMENT OF NPM1-MUTATED AML-MedSci.cn

A DESIGNED HIGH THROUGHPUT DRUG SCREENING STRATEGY IDENTIFIES AURORA KINASE A INHIBITORS AS PROMISING PRECLINICAL CANDIDATES FOR THE TREATMENT OF NPM1-MUTATED AML

Ranieri, R; Neuenschwander, M; Kleissle, S; Mezzasoma, F; Silvestri, S; Ferrari, A; Pierangeli, S; Donnini, S; Milano, F; Sabino, M; Tini, V; Spinozzi, G; Falini, B; von Kries, JP; Gionfriddo, I; Martelli, MP

HAEMATOLOGICA, 2022; 107 (): 20

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

A DESIGNED HIGH THROUGHPUT DRUG SCREENING STRATEGY IDENTIFIES AURORA KINASE A INHIBITORS AS PROMISING PRECLINICAL CANDIDATES FOR THE TREATMENT OF NPM1-MUTATED AML

科室

工具

服务